STEMLIFE BHD
KLSE (MYR): STEMLFE (0137)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.565
Today's Change
0.00 (0.00%)
Day's Change
0.00 - 0.00
Trading Volume
0
Overview
Market Cap
NOSH
Avg Volume (4 weeks)
4 Weeks Range
4 Weeks Price Volatility (%)
%
52 Weeks Range
52 Weeks Price Volatility (%)
%
Previous Close
Open
Bid
Ask
Day's Range
Trading Volume
Financial Highlight
Latest Quarter | Ann. Date
31-Dec-2016 [#2] | 08-Feb-2017
Next QR | Est. Ann. Date
31-Mar-2017 | 10-May-2017
T4Q P/E | EY
67.00 | 1.49%
T4Q DY | Payout %
0.00% | 0.00%
T4Q NAPS | P/NAPS
0.11 | 5.33
T4Q NP Margin | ROE
9.85% | 7.96%
Market Buzz
News and Blogs
No result.
Company Profile
Sector: HEALTH CARE
Sector: HEALTH CARE
Subsector: HEALTH CARE PROVIDERS
Subsector: HEALTH CARE PROVIDERS
Description:
StemLife Berhad (StemLife) is a blood stem cell banking and storage services provider. StemLife is engaged in the stem cell therapy and stem cell consultancy services; collection, testing, processing and preservation of umbilical cord blood stem cells; testing, processing and preservation of blood stem cells, and investment holding. The Company's subsidiaries include Stemlife Properties Sdn. Bhd., which is a investment holding company; Stemlife Therapeutics Sdn. Bhd., which is engaged in harvesting, testing, processing and preservation of peripheral blood stem cells, and Stemlife Logistics Sdn. Bhd, which is engaged in logistics of umbilical cord blood stem cells and blood stem cells. On December 21, 2010, the Company acquired Stemvet Sdn. Bhd., being a subsidiary of Stemlife Therapeutics Sdn. Bhd. also became a wholly owned subsidiary of Stemlife Berhad 27% interest in Stemlife Therapeutics Sdn. Bhd.
Discussions
2 people like this. Showing 50 of 690 comments
good qr result, this stock will trend up a while before profit taking.. tp: 43
2015-11-11 08:37
oh my,,,,,,,,45sen so low and close to current price, no excitement tmr!!
2015-11-12 19:23
StemLife Receives Takeover Offer At RM0.45 Per Share
Stem cell banking company StemLife has received a mandatory takeover offer from its major shareholder, Singapore-listed Cordlife Group, to acquire the remaining 67 percent stake it does not own in the company for RM0.45 per share.
The take-over offer was triggered after Cordlife, already a major shareholder of firm, crossed the 33 percent threshold with the purchase of 3 million shares or 1.2 percent of the company on 12 November.
Other notable shareholders in StemLife include Berjaya Corporation (10 percent) and JP Morgan Chase (4.6 percent). The company has said that its board will hold a meeting to deliberate the offer and make an announcement in due course.
Significance: The offer price of RM0.45 represents a RM0.025 or 5.9 percent premium against StemLife’s closing price of RM0.425 on 12 November. It was noted that Cordlife does not intend to maintain the listing status of the firm if the all-cash offer, which is worth RM1.4 billion, goes through.
2015-11-14 10:30
What's the rationale for buying above offer price RM0.45? Are these buyers going to reject the offer?
2015-12-04 22:52
Do not sell this counter. Cordlife has bigger plans but want it cheap. The regenerative industry is starting to pick up. The assets of this company is substantial,cash and real estate. The business is still profitable. If not Cordlife would not buy.
2015-12-06 17:53
CordLife has been buying @o.45 in open market to ensure its takeover bid wld be successful. This C9 has good potential to grow exponentially. Look at TMC, the share wld be 50 sen easily if it is still listed.....provided all who have faith in this Co reject the 0.45 offer.
2015-12-06 21:20
Look at Japan, the govt. is supporting their Regenerative Medicine industry. They are buying biotech companies dealing with stem cells. Even Mesoblast of Australia is going to Japan get their products commercially available. Cordlife is doing well making profits and expanding in Asia. So you think they will lose money in Stemlife?? They want to buy cheap lah. The reg med industry will definitely grow in the near future.
2015-12-07 09:17
I strongly agreed with drkschua59.
The reg med industry is the future, either near term or long term.
But, I will make sure the management team is trustworthy & sincere in doing businesses.
There are too many conman management in KLSE. Must be very careful.
2015-12-08 11:22
The present board of directors is definitely more professionally qualified. Except I don't know whether they are more loyal to Cordlife or dedicated to rejunavate Stemlife. The business is ongoing and the staff are working hard. One client of cord tissue banking is worth 3 of cord blood. I hope they cannot gather enough shares to take it private. I want the board to give more back to loyal shareholders. The board have not explained to the sharehokders why it is so important to take it private. Perhaps they want to enrich Cordlife and themselves. They should offer in exchange some cordlife shares.
2015-12-08 19:49
If Stemlife is still listed, 3 years is the minimum. There is no other counter that deals with stem cells and hence no competitor. TMC does NOT have any stem cell business anymore.
2015-12-09 16:59
sorry im newbie here, what do you mean if is still listed? If i get in the train tomorrow, and privatise no more listing, what will impact on us as share holder?
2015-12-09 20:33
if privatise, you will get a pay check depending on the amount of shares you have. You will not want to hold shares in a privatise company
2015-12-10 09:21
will we be notified if company being privatise? Is there a chances that company pay lower than share market price?
2015-12-10 15:19
good or bad news? :) http://www.prnewswire.co.uk/news-releases/biosafe-and-stemlife-sign-a-long-term-supply-agreement-561378141.html
2015-12-10 15:38
Basically Stemlife is here to stay for a long time. As i have said Cordlife sees great future but they want it all for themself. Taking it private also mean doing a lot more without having to face both the shareholders and the securities commission. More can be achieved this way and when they want to cash out again, they relist when the situation is much better ie when regenerative medicine industry is booming.
2015-12-10 17:19
PUBLIC SHAREHOLDINGS SPREAD
STEMLIFE BERHAD
Type Announcement
Subject PUBLIC SHAREHOLDINGS SPREAD
Description StemLife Berhad ("StemLife" or "The Company")
Non-compliance with Public Shareholding Spread pursuant to Rule 8.02(1) of the ACE Market Listing Requirements ("LR") of Bursa Malaysia Securities Berhad ("Bursa Securities")
We refer to the announcements dated 22 December 2015, 23 December 2015 and 28 January 2016 and 11 February 2016 (“Earlier Announcements”). Unless otherwise stated, all definitions and terms used in this announcement shall have the same meaning as stated in the Earlier Announcements in relation to the Public Shareholdings Spread.
The Board of Directors wishes to announce that the Company will be applying to Bursa Securities for an extension of time in order to implement the necessary procedures to withdraw its listing status from the Official List of Bursa Securities in accordance with Chapter 16 of the LR.
This announcement is dated 16 February 2016.
2016-02-17 14:28
Wat lar...this company not yet taken over completely...no more AGM??? 48c Q-ing to buy many lots no sellers, including me who holds on tight to my shares :D
2016-05-27 14:27
When is the cheapskate Cordlife going to raise its takeover price to 50c???
2016-06-14 13:18
Post a Comment
Featured Posts
Apps
Top Articles
1
2
3
diary
4
https://dividendguy67.blogspot.com
5
6
7
8
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
bryan_x00
duit congrats on your omesti!! when is stemlfe turn? hehe
2015-05-30 08:18